Hydroxymatairesinol, a Novel Enterolactone Precursor With Antitumor Properties From Coniferous Tree (Picea abies)

Abstract: The potential for the extraction of the plant lignan hydroxymatairesinol (HMR) in large scale from Norway spruce (Picea abies) has given us the opportunity to study the metabolism and biological actions of HMR in animals. HMR, the most abundant single component of spruce lignans, was metabolized to enterolactone (ENL) as the major metabolite in rats after oral administration. The amounts of urinary ENL increased with the dose of HMR (from 3 to 50 mg/kg), and only minor amounts of unmetabolized HMR isomers and other lignans were found in urine. HMR (15 mg/kg body wt po) given for 51 days decreased the number of growing tumors and increased the proportion of regressing and stabilized tumors in the rat dimethylbenz[a]anthracene-induced mammary tumor model. HMR (50 mg/kg body wt) did not exert estrogenic or antiestrogenic activity in the uterine growth test in immature rats. HMR also showed no antiandrogenic responses in the growth of accessory sex glands in adult male rats. Neither ENL nor enterodiol showed estrogenic or antiestrogenic activity via a classical a- or b-type estrogen receptor-mediated pathway in vitro at <1.0 mM. HMR was an effective antioxidant in vitro.

[1]  L. Thompson,et al.  Biochemical and Molecular Roles of Nutrients Flaxseed and Its Lignan Precursor , Secoisolariciresinol Diglycoside , Affect Pregnancy Outcome and Reproductive Development in Rats 1 , 2 , 3 , 1998 .

[2]  G. Hallmans,et al.  Inhibitory effects of soy and rye diets on the development of Dunning R3327 prostate adenocarcinoma in rats , 1998, The Prostate.

[3]  J. Gustafsson,et al.  Differential response of estrogen receptor alpha and estrogen receptor beta to partial estrogen agonists/antagonists. , 1998, Molecular pharmacology.

[4]  R. Ekman,et al.  NMR-SPECTROSCOPIC STUDY OF HYDROXYMATAIRESINOL, THE MAJOR LIGNAN IN NORWAYSPRUCE (PICEA ABIES) HEARTWOOD , 1998 .

[5]  J. Gustafsson,et al.  Differential Response of Estrogen Receptor a and Estrogen Receptor b to Partial Estrogen Agonists/Antagonists , 1998 .

[6]  D. Ingram,et al.  Case-control study of phyto-oestrogens and breast cancer , 1997, The Lancet.

[7]  L. Kangas,et al.  Antioxidant properties of the triphenylethylene antiestrogen drug toremifene , 1997, Naunyn-Schmiedeberg's Archives of Pharmacology.

[8]  G. Hallmans,et al.  Soy and rye diets inhibit the development of Dunning R3327 prostatic adenocarcinoma in rats. , 1997, Cancer letters.

[9]  J. Schenker,et al.  Short‐term Effects of Phytoestrogen‐rich Diet on Postmenopausal Women , 1997 .

[10]  L. Thompson,et al.  Dose-dependent production of mammalian lignans in rats and in vitro from the purified precursor secoisolariciresinol diglycoside in flaxseed. , 1996, The Journal of nutrition.

[11]  L. Thompson,et al.  Flaxseed and its lignan and oil components reduce mammary tumor growth at a late stage of carcinogenesis. , 1996, Carcinogenesis.

[12]  M. Jenab,et al.  The influence of flaxseed and lignans on colon carcinogenesis and beta-glucuronidase activity. , 1996, Carcinogenesis.

[13]  L. Thompson,et al.  Antitumorigenic effect of a mammalian lignan precursor from flaxseed. , 1996, Nutrition and cancer.

[14]  K. Griffiths,et al.  Inhibition of 5 alpha-reductase in genital skin fibroblasts and prostate tissue by dietary lignans and isoflavonoids. , 1995, The Journal of endocrinology.

[15]  H. Adlercreutz,et al.  Lignans and flavonoids inhibit aromatase enzyme in human preadipocytes , 1994, The Journal of Steroid Biochemistry and Molecular Biology.

[16]  M. Martini,et al.  Urinary lignan and isoflavonoid excretion in premenopausal women consuming flaxseed powder. , 1994, The American journal of clinical nutrition.

[17]  L. Thompson.  Antioxidants and hormone-mediated health benefits of whole grains. , 1994, Critical reviews in food science and nutrition.

[18]  M. Martini,et al.  Effect of flax seed ingestion on the menstrual cycle. , 1993, The Journal of clinical endocrinology and metabolism.

[19]  I. Huhtaniemi,et al.  A supersensitive immunofluorometric assay for rat luteinizing hormone. , 1993, Endocrinology.

[20]  H. Adlercreutz,et al.  Inhibition of human aromatase by mammalian lignans and isoflavonoid phytoestrogens , 1993, The Journal of Steroid Biochemistry and Molecular Biology.

[21]  H. Adlercreutz,et al.  Enterolactone and estradiol inhibit each other's proliferative effect on MCF-7 breast cancer cells in culture , 1992, The Journal of Steroid Biochemistry and Molecular Biology.

[22]  L. Thompson,et al.  The effect of flaxseed supplementation on the initiation and promotional stages of mammary tumorigenesis. , 1992, Nutrition and cancer.

[23]  L. Thompson,et al.  The effect of flaxseed supplementation on early risk markers for mammary carcinogenesis. , 1991, Cancer letters.

[24]  T. Shultz,et al.  Effect of short-term flaxseed consumption on lignan and sex hormone metabolism in men , 1991 .

[25]  K. Catt,et al.  Newborn and immature rat testes contain gonadotropin-releasing hormone (GnRH) receptors, and their testosterone production is stimulated by a GnRH agonist in vitro , 1985, Molecular and Cellular Endocrinology.

[26]  A. Waters,et al.  Effect of a lignan (HPMF) on RNA synthesis in the rat uterus. , 1982, Journal of reproduction and fertility.

[27]  J. Sjövall,et al.  Origin of lignans in mammals and identification of a precursor from plants , 1982, Nature.

[28]  L. C. Anderson,et al.  LIGNAN FORMATION IN MAN—MICROBIAL INVOLVEMENT AND POSSIBLE ROLES IN RELATION TO CANCER , 1981, The Lancet.

[29]  M. Axelson,et al.  The excretion of lignans in rats — evidence for an intestinal bacterial source for this new group of compounds , 1981, FEBS letters.

[30]  V. Jordan,et al.  A monohydroxylated metabolite of tamoxifen with potent antioestrogenic activity. , 1977, The Journal of endocrinology.

[31]  R. Ekman.  Analysis of Lignans in Norway Spruce by Combined Gas Chromatography — Mass Spectrometry , 1976 .